Home > Financial Ratios > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EBIT Growth(%) 24.0847.24-21.1914.7853.68

What is the latest EBIT Growth ratio of TORRENT PHARMACEUTICALS ?

The latest EBIT Growth ratio of TORRENT PHARMACEUTICALS is 24.08 based on Mar2024 Consolidated results.
Year EBIT Growth
Mar202424.08
Mar202347.24
Mar2022-21.19
Mar202114.78
Mar202053.68

How is EBIT Growth of TORRENT PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2024 24.08
-49.03
Mar2023 47.24
Positive
Mar2022 -21.19
Negative
Mar2021 14.78
-72.47
Mar2020 53.68 -

Other Financial Ratios of TORRENT PHARMACEUTICALS


Compare EBIT Growth ratio of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹109,189.8 Cr 1.4% -1.5% 13.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹395,326.0 Cr -2.5% -4.7% 11.9% Stock Analytics
DIVIS LABORATORIES ₹173,562.0 Cr -2.7% -0.7% 50.4% Stock Analytics
CIPLA ₹121,023.0 Cr -1.2% 0.8% -0.9% Stock Analytics
DR REDDYS LABORATORIES ₹109,558.0 Cr -2.3% 8.2% 11.1% Stock Analytics
MANKIND PHARMA ₹97,164.6 Cr -1.1% -8.1% 6.5% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

1.4%

-1.5%

13.3%

SENSEX

-1.3%

-0.8%

6.3%


You may also like the below Video Courses